The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.
TARGETING HEME PHARMACOLOGICALLY TO TREAT SEVERE FORMS OF MALARIA. Miguel Amado Franco Parreira Soares, Fundação Calouste Gulbenkian (FCG). €176,563.
The impact of exendin-4 therapy in the molecular mechanisms underlying type 2 diabetes-related long-term brain dysfunction. Ana Isabel Marques Duarte, Centro de Neurociências e Biologia Celular (CNBC/UC). €144,305.
Regulatory effects of pattern recognition receptors (PRRs) in electrolyte transport and membrane potential in intestinal epithelial cells. Fernando José Magro Dias, Faculdade de Medicina da Universidade do Porto (FM/UP). €117,475.
Role of mitochondrial p66Shc in drug-induced mitochondrial toxicity memory. Ignacio Vega Naredo, Centro de Neurociências e Biologia Celular (CNBC/UC). €79,291.
Metabolic profiling: a novel tool for evaluation of the toxicological and biological effects of nanomaterials. Iola Melissa Fernandes Duarte, Universidade de Aveiro (UA). €152,445.
Personalized 3D vascular constructs for toxicity assessment- VASCTOX. Mário Martins Rodrigues Grãos, BIOCANT - Associação de Transferência de Tecnologia (BIOCANT). €141,755.
Physiopathological role of ecto-5`-nucleotidase - a new target for neuroprotection. Rodrigo Antunes Cunha, Centro de Neurociências e Biologia Celular (CNBC/UC). €147,605.